enVVeno Medical (NVNO) Current Assets (2017 - 2026)

enVVeno Medical's Current Assets history runs 10 years deep, the most recent figure standing at $25.5 million for Q1 2026.

• On a quarterly basis, Current Assets fell 35.44% year-over-year to $25.5 million in Q1 2026; TTM through Mar 2026 was $25.5 million, a 35.44% decrease from a year earlier, with the FY2025 full-year figure at $28.8 million, down 34.09% from the prior year.
• Current Assets declined to $25.5 million in Q1 2026 per NVNO's latest filing, from $28.8 million in the prior quarter.
• Across five years, Current Assets topped out at $51.6 million in Q1 2022 and bottomed at $25.5 million in Q1 2026.
• The 5-year median for Current Assets is $39.4 million (2022), against an average of $37.9 million.
• Across the five-year window, Current Assets jumped 87.1% in 2024 and sank 35.78% in 2025, its largest moves.
• Year by year, Current Assets stood at $39.4 million in 2022, then advanced by 18.99% to $46.9 million in 2023, then retreated by 6.8% to $43.7 million in 2024, then slumped by 34.09% to $28.8 million in 2025, then declined by 11.58% to $25.5 million in 2026.
• Per Business Quant, the three latest NVNO Current Assets figures stand at $25.5 million (Q1 2026), $28.8 million (Q4 2025), and $31.5 million (Q3 2025).